Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
11.19
-0.14 (-1.24%)
At close: Mar 30, 2026, 4:00 PM EDT
11.27
+0.08 (0.71%)
After-hours: Mar 30, 2026, 5:02 PM EDT
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $1.44 billion as of March 30, 2026. Its market cap has increased by 155.60% in one year.
Market Cap
1.44B
Enterprise Value
1.25B
1-Year Change
155.60%
Ranking
Category
Stock Price
$11.19
Market Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $1.44B, an increase of 1,590.53%. That is a compound annual growth rate of 50.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 1.45B | -9.39% |
| Dec 31, 2025 | 1.61B | 336.04% |
| Dec 31, 2024 | 368.19M | 330.28% |
| Dec 29, 2023 | 85.57M | -26.01% |
| Dec 30, 2022 | 115.65M | 472.04% |
| Dec 31, 2021 | 20.22M | -54.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nurix Therapeutics | 1.53B |
| Maze Therapeutics | 1.51B |
| Palvella Therapeutics | 1.51B |
| Vericel | 1.49B |
| Immunocore Holdings | 1.49B |
| Nanobiotix | 1.48B |
| Intellia Therapeutics | 1.46B |
| Oculis Holding AG | 1.46B |